Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.

Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progr...

Full description

Bibliographic Details
Main Authors: Gonçalo da Costa, Cristina Ribeiro-Silva, Raquel Ribeiro, Samuel Gilberto, Ricardo A Gomes, António Ferreira, Élia Mateus, Eduardo Barroso, Ana V Coelho, Ana Ponces Freire, Carlos Cordeiro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4492746?pdf=render
_version_ 1818285739486478336
author Gonçalo da Costa
Cristina Ribeiro-Silva
Raquel Ribeiro
Samuel Gilberto
Ricardo A Gomes
António Ferreira
Élia Mateus
Eduardo Barroso
Ana V Coelho
Ana Ponces Freire
Carlos Cordeiro
author_facet Gonçalo da Costa
Cristina Ribeiro-Silva
Raquel Ribeiro
Samuel Gilberto
Ricardo A Gomes
António Ferreira
Élia Mateus
Eduardo Barroso
Ana V Coelho
Ana Ponces Freire
Carlos Cordeiro
author_sort Gonçalo da Costa
collection DOAJ
description Transthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.
first_indexed 2024-12-13T01:13:29Z
format Article
id doaj.art-106c2bbc25cd438fb955ea5bf82f2744
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T01:13:29Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-106c2bbc25cd438fb955ea5bf82f27442022-12-22T00:04:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e012539210.1371/journal.pone.0125392Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.Gonçalo da CostaCristina Ribeiro-SilvaRaquel RibeiroSamuel GilbertoRicardo A GomesAntónio FerreiraÉlia MateusEduardo BarrosoAna V CoelhoAna Ponces FreireCarlos CordeiroTransthyretin amyloidosis is a conformational pathology characterized by the extracellular formation of amyloid deposits and the progressive impairment of the peripheral nervous system. Point mutations in this tetrameric plasma protein decrease its stability and are linked to disease onset and progression. Since non-mutated transthyretin also forms amyloid in systemic senile amyloidosis and some mutation bearers are asymptomatic throughout their lives, non-genetic factors must also be involved in transthyretin amyloidosis. We discovered, using a differential proteomics approach, that extracellular chaperones such as fibrinogen, clusterin, haptoglobin, alpha-1-anti-trypsin and 2-macroglobulin are overrepresented in transthyretin amyloidosis. Our data shows that a complex network of extracellular chaperones are over represented in human plasma and we speculate that they act synergistically to cope with amyloid prone proteins. Proteostasis may thus be as important as point mutations in transthyretin amyloidosis.http://europepmc.org/articles/PMC4492746?pdf=render
spellingShingle Gonçalo da Costa
Cristina Ribeiro-Silva
Raquel Ribeiro
Samuel Gilberto
Ricardo A Gomes
António Ferreira
Élia Mateus
Eduardo Barroso
Ana V Coelho
Ana Ponces Freire
Carlos Cordeiro
Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
PLoS ONE
title Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
title_full Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
title_fullStr Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
title_full_unstemmed Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
title_short Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
title_sort transthyretin amyloidosis chaperone concentration changes and increased proteolysis in the pathway to disease
url http://europepmc.org/articles/PMC4492746?pdf=render
work_keys_str_mv AT goncalodacosta transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT cristinaribeirosilva transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT raquelribeiro transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT samuelgilberto transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT ricardoagomes transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT antonioferreira transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT eliamateus transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT eduardobarroso transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT anavcoelho transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT anaponcesfreire transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease
AT carloscordeiro transthyretinamyloidosischaperoneconcentrationchangesandincreasedproteolysisinthepathwaytodisease